pharma · Colon Carcinoma Metastatic in the Liver · Metastatic Melanoma · VCNX
Vaccinex
VACCINEX, INC.
Vaccinex trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
1895 Mt Hope Ave, Rochester, New York 14620, US HQ
28 Employees
Public company Type
VCNX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1895 Mt Hope Ave, Rochester, New York 14620, US
- Employees
- 28
- Programs
- 11
- Drugs
- 8
- Patents
- 41
Vaccinex clinical trials
Registry index of 11 ClinicalTrials.gov studies linked to Vaccinex programs — each row shows trial ID, program name, phase, status, and indication.
Vaccinex trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Vaccinex.
-
Anti-SEMA4D Monoclonal Antibody VX15/2503 — Phase 1
Clinical update -
Anti-SEMA4D Monoclonal Antibody VX15/2503 — Phase 1
Clinical update -
Dendritic Cell (DC1) Vaccine — Phase 1
Clinical update -
Avelumab and Pepinemab — Phase 2
Clinical update -
VX15/2503 — Phase 2
Clinical update -
VX15/2503 + avelumab — Phase 2
Clinical update -
pepinemab + pembrolizumab — Phase 2
Clinical update -
Ipilimumab — Phase 1
Clinical update